Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atofil was a U.S.-based private company involved in manufacturing, packaging, labeling, and marketing dietary supplements and related consumer health products. Publicly available regulatory records link the company to kratom-containing supplements and tianeptine-containing products sold under brands such as Tianaa Red, Tianaa White, and Tianaa Green. The company appears to have operated as a subsidiary or affiliated entity of Premier Manufacturing Products and maintained operations in Florida. Available evidence does not indicate that Atofil was a biotech or pharmaceutical drug developer with a conventional therapeutic pipeline; instead, it functioned primarily as a commercial-stage manufacturer and marketer of regulated consumer ingestible products. As of recent business-registry records, the Florida entity is listed as inactive.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atofil.